Antibody Response to COVID-19 Vaccination Not Affected by Whether RA Patients Interrupt DMARD Therapy
In an observational study in “real-world” practice, Brigham and Women’s Hospital researchers did not identify significant differences in antibody response to COVID-19 vaccination among rheumatoid arthritis patients who held versus continued disease-modifying anti-rheumatic drugs for the last dose of the primary series.
Read More...